Health Rounds: AstraZeneca drug reduces lung disease flare-ups in late-stage trials
By Nancy LapidHello Health Rounds readers! Today we feature data from studies being presented at the ongoing European Respiratory Society Congress in Barcelona.Experimental drug reduces lung-disease flaresA drug being developed by AstraZeneca LSE:AZN significantly reduced flare-ups of chronic obstr…
By Nancy LapidHello Health Rounds readers! Experimental drug reduces lung-disease flaresA drug being developed by AstraZeneca LSE:AZN significantly reduced flare-ups of chronic obstr…